inclusion criteria: * covid-19 infection confirmed by sars-cov2 - rt pcr - as per protocol * able to start the treatment within 24 hours from time of diagnosis * patient with mild symptoms as defined by who, with pao2 \> 93% * signed written consent of the patient * accepts and has the ability to be reached by phone during the study duration, plus a designated a contact person who can be contacted in case of emergency

inclusion criteria: * covid-19 infection confirmed by sars-cov2 - rt pcr - as per protocol * able to start the treatment within 24 hours from time of diagnosis * patient with mild symptoms as defined by who, with pao2 \> 93% * signed written consent of the patient * accepts and has the ability to be reached by phone during the study duration, plus a designated a contact person who can be contacted in case of emergency

inclusion criteria: - covid-19 infection confirmed by sars-cov2 - rt pcr - as per protocol - able to start the treatment within 24 hours from time of diagnosis - patient with mild symptoms as defined by who, with pao2 > 93% - signed written consent of the patient - accepts and has the ability to be reached by phone during the study duration, plus a designated a contact person who can be contacted in case of emergency

inclusion criteria: - covid-19 infection confirmed by sars-cov2 - rt pcr - as per protocol - able to start the treatment within 24 hours from time of diagnosis - patient with mild symptoms as defined by who, with pao2 > 93% - signed written consent of the patient - accepts and has the ability to be reached by phone during the study duration, plus a designated a contact person who can be contacted in case of emergency